Draft Guide On Rx-Price Reports Rekindles Debate Over Non-Interference

Pharmacies support CMS' draft guidance on how Part D sponsors should report prices concessions negotiated with pharmacies, but critics such as the Pharmaceutical Care Management Association say it violates the "non-interference clause" of the Social Security Act and will drive up drug costs for beneficiaries. CMS' draft guidance asks Part D sponsors to report price concessions that can be reasonably approximated at the point of sale as part of their negotiated prices with pharmacies. The National Community Pharmacists Association and...